文献速递新生儿儿童感染

中东地区新生儿早发型脓毒症的病原与耐药系统综述

Neonatal early onset sepsis in Middle Eastern countries: a systematic review.
PubMed 文献 · Arch Dis Child · 2020-01-22

该系统综述纳入2000年后中东10国33项研究,分析2215例培养阳性早发型脓毒症(EOS)病例。中等收入国家以克雷伯菌、金黄色葡萄球菌和大肠埃希菌为主,对氨苄西林/庆大霉素及三代头孢菌素敏感率仅40%和37%;高收入国家以B族链球菌、大肠埃希菌为主,敏感率分别为93%和91%。

要点

  • 中东中等收入国家EOS以革兰阴性菌为主且经验性抗生素敏感率低。
  • 高收入国家EOS以B族链球菌和大肠埃希菌为主,敏感率较高。
  • 地区间病原谱和耐药差异对新生儿死亡率有重要公共卫生意义。

核心结论

  • 中东中等收入国家EOS更可能由革兰阴性病原体引起,且对经验性抗生素治疗敏感率更低。

研究设计与样本

  • 系统综述检索Medline、Web of Science、Cochrane Library和Index Medicus for the Eastern Mediterranean Region,纳入2000年1月后发表、中东地区、早发型脓毒症数据、无语言限制的文献,采用纽卡斯尔-渥太华量表评估偏倚风险,方案注册于PROSPERO(CRD42017060662)。

主要发现

  • 共纳入来自10个国家的33篇文章,分析2215例培养阳性EOS病例(排除凝固酶阴性葡萄球菌)。
  • 中等收入国家最常见病原体为克雷伯菌属(26%)、金黄色葡萄球菌(17%)和大肠埃希菌(16%)。
  • 高收入国家最常见病原体为B族链球菌(26%)、大肠埃希菌(24%)和克雷伯菌(9%)。
  • 中等收入国家对氨苄西林/庆大霉素和三代头孢菌素的总体敏感率分别为40%和37%,高收入国家分别为93%和91%。

关键数值与推荐

  • 纳入标准:2000年1月后发表、中东地区数据、早发型脓毒症特异性数据、无语言限制。
  • 排除凝固酶阴性葡萄球菌作为可能污染菌的数据。
  • 中等收入国家EOS对氨苄西林/庆大霉素敏感率40%,对三代头孢菌素敏感率37%。
  • 高收入国家EOS对氨苄西林/庆大霉素敏感率93%,对三代头孢菌素敏感率91%。

临床怎么用

  • 在中东中等收入国家,经验性抗生素选择需考虑革兰阴性菌高比例及低敏感率,可能需调整指南。
  • 高收入国家当前经验性方案敏感率较高,但需持续监测病原谱变化。

局限性

  • 研究聚焦EOS但包含晚发型脓毒症抗生素敏感数据,可能引入异质性。
  • 排除凝固酶阴性葡萄球菌可能影响病原谱完整性。
  • 仅纳入中东地区研究,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Early onset neonatal sepsis (EOS) accounts for a significant portion of neonatal mortality, which accounts for 46% of global under five child mortality. OBJECTIVE: This systematic review studies the bacterial aetiology of EOS in the Middle East, susceptibility patterns to recommended empirical antibiotic therapy and whether this differs between high-income and middle-income countries in the region. METHODS: Articles were collected from Medline, Web of Science, the Cochrane Library and Index Medicus for the Eastern Mediterranean Region. The articles included in our systematic review met the following criteria: published after January 2000, data relevant to the Middle East, data specific for early onset sepsis, no language restriction. Data on aetiology and susceptibility were extracted from prospective and retrospective studies. Risk of bias was assessed using the Newcastle-Ottawa Scale. This study focused on EOS but does include data regarding neonatal late-onset sepsis antibiotic susceptibility. The data regarding coagulase-negative Staphylococcus species were excluded from final analysis, as possible contaminants. The protocol for this systematic review was registered on PROSPERO: CRD42017060662. RESULTS: 33 articles from 10 countries were included in the analysis. There were 2215 cases of culture-positive EOS, excluding coagulase-negative Staphylococcus. In middle-income countries, Klebsiella species (26%), Staphylococcus aureus (17%) and Escherichia coli (16%) were the most common pathogens, in contrast to group B Streptococcus (26%), E. coli (24%) and Klebsiella (9%) in high-income countries. Overall susceptibility to ampicillin/gentamicin and third-generation cephalosporin were 40% and 37%, respectively, in middle-income countries versus 93% and 91%, respectively, in high-income countries. CONCLUSIONS: EOS in middle-income countries was more likely to be due to Gram-negative pathogens and less likely to be susceptible to empirical antibiotic therapy. This has important public health implications regarding neonatal mortality in the Middle East region.

来源:Arch Dis Child,查看原文。版权归原作者所有。

引用

  1. Khalil N, Blunt HB, Li Z, et al. Neonatal early onset sepsis in Middle Eastern countries: a systematic review. Arch Dis Child. 2020. PMID: 31969351. doi:10.1136/archdischild-2019-317110

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。